GE published a regulatory filing about the spinoff of its healthcare unit, which it expects to complete in the first week of 2023, if the transaction is approved by its board of directors. GE HealthCare will be listed on the Nasdaq under the ticker “GEHC.”

On September 21, 2022, Lepu Medical was officially listed on the SIX Swiss Exchange. It is a critical milestone in the development of Lepu Medical and a brand new point for the company's comprehensive internationalization strategy.

On September 9, 2022, MGI Tech Co., Ltd. was listed on the STAR Market. The stock name is Huada Zhizao, the stock code is 688114. SH, with the issue price is 87.18 CNY / share, and the opening price is 107 CNY / share. MGI is an affiliated company of the Listed Company BGI.

On August 26, Dian Diagnostics achieved operating income of CNY 10.753 billion, an increase of 85.68% over the same period last year; net profit attributable to the parent was CNY 1.880 billion, an increase of 158.54% over the same period last year.

Gongdong Medical recently released its 2022 semi-annual report, in which the company achieved operating revenue of CNY 799 million, an increase of 38.70% year-on-year; net profit attributable to shareholders of the listed company was CNY 211 million, an increase of 18.92% year-on-year.

According to the news on August 8, Beijing Savant Biotechnology Co., ltd. (Stock Code No.: 873748) was listed on the New OTC Market.

On July 28, Innovita Biological Technology Co., Ltd. was listed on the SSE STAR Market with the stock code of 688253. Its issue price was CNY 26.06 per share. After the opening, the market value exceeded CNY 4.6 billion.

Abbott said on Wednesday that COVID-19 testing demand has continued throughout its second quarter, driving its Diagnostics business revenues up 33 percent year over year.

Zhiyan Consulting Data Center released the net profit ranking of Chinese medical device listed companies in the first quarter of 2022, ranking 109 Chinese listed medical companies according to their net profit in the first quarter of 2022.

On June 22, China IPO learned that Mega Genomics (06667.HK) was officially listed on Hong Kong Exchanges and Clearing Limited today.